WEBSITE BSE:526169 NSE: MULTIBASE I Inc. Year: 1991 Industry: Petrochemicals My Bucket: Add Stock
Last updated: 11:23
No Notes Added Yet
1. Business Overview
Multibase India Ltd. operates in the petrochemical sector, specifically focusing on the manufacturing of specialty polymer compounds and additives. Its core business model involves developing, producing, and marketing specialized chemical solutions primarily for the plastics and polymer processing industries. The company makes money by selling these value-added products, which enhance the properties and performance of plastics used in various applications.
2. Key Segments / Revenue Mix
While specific segment details are not publicly available, companies like Multibase India typically cater to diverse end-user industries. Its product portfolio likely includes a range of polymer additives, masterbatches, and engineering plastic compounds. These products serve sectors such as automotive, packaging, consumer goods, electrical & electronics, and construction. The revenue mix would primarily be derived from the sale of these specialized chemical formulations.
3. Industry & Positioning
The Indian petrochemical industry is a capital-intensive and cyclical sector, heavily influenced by crude oil prices and demand from downstream industries. It's characterized by both large integrated players and specialized manufacturers. Multibase India is positioned as a niche player in the specialty chemicals segment within petrochemicals, focusing on value-added polymer compounds rather than basic bulk chemicals. This strategy allows it to differentiate itself by offering customized solutions and technical expertise, competing with both domestic and international specialty chemical producers.
4. Competitive Advantage (Moat)
Multibase India's potential competitive advantages could stem from:
Proprietary Formulations & R&D: The ability to develop unique and high-performance polymer compounds and additives through ongoing research.
Technical Expertise & Customer Relationships: Providing tailored solutions and technical support to clients, leading to strong customer loyalty and sticky relationships.
Product Performance & Quality: Consistent delivery of high-quality products that meet stringent industry standards, especially in demanding applications.
Regulatory Approvals: Obtaining necessary certifications and approvals for its products, which can be a barrier to entry for new competitors.
5. Growth Drivers
Key factors that can drive growth for Multibase India over the next 3-5 years include:
Industrial Growth: Expansion of manufacturing sectors in India, particularly automotive, packaging, and infrastructure, which are major consumers of plastics and polymers.
Increasing Plastic Consumption: Rising per capita consumption of plastics and growing demand for high-performance polymer solutions.
Product Innovation & Diversification: Introduction of new and advanced compounds to meet evolving industry needs and penetrate new application areas.
Import Substitution: Opportunities to replace imported specialty chemicals with domestically produced alternatives.
Sustainability Trends: Growing demand for eco-friendly or performance-enhancing additives that contribute to lightweighting or recycling efforts.
6. Risks
Raw Material Price Volatility: Significant dependence on crude oil derivatives and other petrochemical feedstocks, making the company susceptible to price fluctuations.
Intense Competition: Facing competition from both domestic and international players, leading to pricing pressures.
Economic Downturns: A slowdown in end-user industries (e.g., automotive, construction) can directly impact demand for its products.
Regulatory Changes: Stricter environmental norms or changes in import/export policies could affect operations and costs.
Technological Obsolescence: Failure to innovate or keep pace with new material science developments could erode market share.
7. Management & Ownership
Multibase India Ltd. is likely a promoter-driven company, a common structure in India. Promoters typically hold a significant stake and are often directly involved in strategic decision-making and operational oversight. The management quality would depend on their experience, vision, and ability to navigate the cyclical petrochemical industry and drive innovation in specialty chemicals. Specific details on the individual management team and granular ownership structure are not provided here.
8. Outlook
Multibase India operates in a segment with structural growth tailwinds driven by India's industrialization and increasing per capita consumption of plastics. The bull case rests on the company's ability to capitalize on this demand by continually innovating its product portfolio, maintaining strong customer relationships, and managing raw material costs effectively. Diversification into high-value applications and potential export opportunities could further boost growth. The bear case, however, highlights vulnerability to volatile crude oil prices, intense competition that could compress margins, and a slowdown in key end-user industries. Regulatory changes regarding plastic usage or environmental compliance could also pose challenges. The company's performance will largely depend on its agility in product development and its ability to navigate the inherent cyclicality and raw material dependency of the petrochemical sector.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Market Cap ₹249 Cr.
Stock P/E 17
P/B 2.9
Current Price ₹197.3
Book Value ₹ 68.9
Face Value 10
52W High ₹308.4
Dividend Yield 26.86%
52W Low ₹ 156
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
| #(Fig in Cr.) | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 16 | 16 | 15 | 19 | 18 | 17 | 16 | 17 | 19 | 14 |
| Other Income | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 |
| Total Income | 18 | 18 | 17 | 21 | 20 | 18 | 17 | 18 | 19 | 14 |
| Total Expenditure | 15 | 14 | 11 | 16 | 14 | 15 | 11 | 14 | 15 | 8 |
| Operating Profit | 3 | 4 | 6 | 6 | 6 | 3 | 6 | 3 | 4 | 6 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 3 | 4 | 5 | 5 | 6 | 3 | 5 | 3 | 4 | 4 |
| Provision for Tax | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit After Tax | 2 | 3 | 4 | 4 | 4 | 2 | 4 | 2 | 3 | 3 |
| Adjustments | 0 | 0 | -0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 2 | 3 | 4 | 4 | 4 | 2 | 4 | 2 | 3 | 3 |
| Adjusted Earnings Per Share | 1.6 | 2.2 | 3.1 | 3.1 | 3.4 | 1.9 | 3.2 | 1.8 | 2.3 | 2.6 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 62 | 70 | 86 | 109 | 110 | 60 | 53 | 62 | 72 | 65 | 71 | 66 |
| Other Income | 1 | 2 | 2 | 2 | 3 | 4 | 4 | 3 | 5 | 8 | 6 | 4 |
| Total Income | 63 | 72 | 89 | 111 | 113 | 64 | 58 | 65 | 77 | 73 | 77 | 68 |
| Total Expenditure | 51 | 56 | 68 | 80 | 90 | 53 | 47 | 56 | 63 | 56 | 56 | 48 |
| Operating Profit | 12 | 16 | 21 | 31 | 23 | 11 | 11 | 10 | 14 | 16 | 21 | 19 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 11 | 15 | 20 | 30 | 22 | 10 | 10 | 9 | 13 | 15 | 20 | 16 |
| Provision for Tax | 4 | 5 | 7 | 10 | 6 | 2 | 3 | 2 | 3 | 4 | 5 | 4 |
| Profit After Tax | 7 | 10 | 13 | 20 | 15 | 8 | 7 | 6 | 10 | 11 | 15 | 12 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 7 | 10 | 13 | 20 | 15 | 8 | 7 | 6 | 10 | 11 | 15 | 12 |
| Adjusted Earnings Per Share | 5.7 | 7.8 | 10.5 | 15.5 | 12.2 | 6 | 5.3 | 5 | 7.8 | 8.8 | 11.6 | 9.9 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 9% | 5% | 3% | 1% |
| Operating Profit CAGR | 31% | 28% | 14% | 6% |
| PAT CAGR | 36% | 36% | 13% | 8% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -32% | 2% | 1% | -1% |
| ROE Average | 14% | 10% | 8% | 14% |
| ROCE Average | 19% | 14% | 12% | 21% |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 41 | 51 | 64 | 84 | 99 | 107 | 114 | 117 | 126 | 135 | 79 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 5 | 5 | 1 | 1 | 30 | 17 | 4 | 4 | 6 | 6 | 7 |
| Total Current Liabilities | 9 | 7 | 11 | 30 | 10 | 8 | 13 | 13 | 12 | 11 | 13 |
| Total Liabilities | 55 | 63 | 77 | 116 | 139 | 132 | 131 | 135 | 144 | 152 | 98 |
| Fixed Assets | 5 | 8 | 9 | 10 | 10 | 11 | 10 | 11 | 11 | 12 | 13 |
| Other Non-Current Assets | 6 | 5 | 1 | 2 | 31 | 17 | 3 | 3 | 4 | 5 | 5 |
| Total Current Assets | 44 | 50 | 67 | 104 | 99 | 104 | 117 | 121 | 129 | 136 | 80 |
| Total Assets | 55 | 63 | 77 | 116 | 139 | 132 | 131 | 135 | 144 | 152 | 98 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 6 | 5 | 19 | 27 | 23 | 49 | 80 | 91 | 94 | 104 | 111 |
| Cash Flow from Operating Activities | 7 | 7 | 5 | 25 | 5 | 20 | 10 | 5 | 9 | 5 | 6 |
| Cash Flow from Investing Activities | -9 | 7 | 4 | -30 | 32 | -0 | 2 | 1 | 3 | 4 | 3 |
| Cash Flow from Financing Activities | 0 | 0 | 0 | 0 | -11 | 11 | 0 | -2 | -1 | -3 | -71 |
| Net Cash Inflow / Outflow | -1 | 14 | 8 | -5 | 26 | 31 | 12 | 3 | 10 | 6 | -62 |
| Closing Cash & Cash Equivalent | 5 | 19 | 27 | 23 | 49 | 80 | 91 | 94 | 104 | 111 | 48 |
| # | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 5.72 | 7.83 | 10.53 | 15.49 | 12.17 | 5.97 | 5.32 | 5.02 | 7.76 | 8.84 | 11.61 |
| CEPS(Rs) | 6.28 | 8.3 | 11.06 | 16.14 | 12.86 | 6.73 | 6.11 | 5.77 | 8.55 | 9.64 | 12.51 |
| DPS(Rs) | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 1 | 2 | 3 | 53 |
| Book NAV/Share(Rs) | 32.62 | 40.44 | 50.98 | 66.48 | 78.62 | 84.71 | 90.05 | 93.06 | 99.8 | 106.63 | 62.21 |
| Core EBITDA Margin(%) | 15.34 | 17.79 | 19.54 | 25.65 | 17.84 | 10.97 | 12.61 | 10.77 | 13.37 | 12.87 | 20.87 |
| EBIT Margin(%) | 16.11 | 19.42 | 21.13 | 26.82 | 19.85 | 16.68 | 18.41 | 13.9 | 18.32 | 23.28 | 27.82 |
| Pre Tax Margin(%) | 16.02 | 19.33 | 21.05 | 26.79 | 19.81 | 16.66 | 18.38 | 13.78 | 18.18 | 23.09 | 27.77 |
| PAT Margin (%) | 10.58 | 12.62 | 13.77 | 17.53 | 13.97 | 12.61 | 12.55 | 10.12 | 13.52 | 17.18 | 20.66 |
| Cash Profit Margin (%) | 11.62 | 13.39 | 14.47 | 18.26 | 14.76 | 14.22 | 14.41 | 11.63 | 14.9 | 18.73 | 22.25 |
| ROA(%) | 14.14 | 16.74 | 18.95 | 20.33 | 12.04 | 5.56 | 5.12 | 4.78 | 7.04 | 7.54 | 11.71 |
| ROE(%) | 19.21 | 21.42 | 23.03 | 26.38 | 16.77 | 7.32 | 6.09 | 5.49 | 8.04 | 8.56 | 13.76 |
| ROCE(%) | 29.25 | 32.97 | 35.34 | 40.35 | 23.84 | 9.68 | 8.93 | 7.53 | 10.9 | 11.61 | 18.52 |
| Receivable days | 55.31 | 53.49 | 60.7 | 70.48 | 70.16 | 91.82 | 78.07 | 64.72 | 56.39 | 57.39 | 49.17 |
| Inventory Days | 54.8 | 51.68 | 60.62 | 70.52 | 67.94 | 87.25 | 80.47 | 71.77 | 52.99 | 56.98 | 66.11 |
| Payable days | 42.69 | 42.58 | 54.04 | 105.62 | 90.22 | 77.09 | 90 | 80.61 | 62.71 | 57.47 | 47.29 |
| PER(x) | 41.82 | 24.35 | 26.31 | 36.37 | 31.5 | 13.98 | 35.93 | 38.36 | 22.36 | 26.67 | 23.62 |
| Price/Book(x) | 7.34 | 4.71 | 5.43 | 8.48 | 4.88 | 0.99 | 2.12 | 2.07 | 1.74 | 2.21 | 4.41 |
| Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 | 0 | 1.05 | 0.52 | 1.15 | 1.27 | 19.32 |
| EV/Net Sales(x) | 4.61 | 3.09 | 3.73 | 6.07 | 3.95 | 0.43 | 2.81 | 2.38 | 1.59 | 2.88 | 4.17 |
| EV/Core EBITDA(x) | 24.29 | 13.77 | 15.29 | 21.44 | 19.15 | 2.37 | 13.83 | 15.42 | 8.03 | 11.58 | 14.16 |
| Net Sales Growth(%) | 12.98 | 14.05 | 23 | 25.52 | 1.28 | -45.63 | -10.58 | 16.9 | 15.58 | -10.36 | 9.29 |
| EBIT Growth(%) | 44.85 | 38.21 | 34.15 | 46.68 | -27.03 | -54.3 | -1.22 | -11.63 | 52.44 | 13.94 | 30.52 |
| PAT Growth(%) | 42.19 | 36.77 | 34.5 | 47.18 | -21.47 | -50.9 | -10.93 | -5.61 | 54.41 | 13.93 | 31.41 |
| EPS Growth(%) | 42.19 | 36.77 | 34.5 | 47.18 | -21.47 | -50.9 | -10.93 | -5.61 | 54.41 | 13.93 | 31.41 |
| Debt/Equity(x) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Ratio(x) | 5.16 | 6.96 | 5.9 | 3.44 | 9.63 | 12.61 | 9.13 | 9.35 | 10.49 | 11.87 | 6.2 |
| Quick Ratio(x) | 4.06 | 5.18 | 4.22 | 2.66 | 7.97 | 11.21 | 8.19 | 8.38 | 9.8 | 10.84 | 5.13 |
| Interest Cover(x) | 183.92 | 200.18 | 247.97 | 866.81 | 482.79 | 738.72 | 627.43 | 113.34 | 127.71 | 121.92 | 508.57 |
| Total Debt/Mcap(x) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 75 | 75 | 75 | 75 | 75 | 75 | 75 | 75 | 75 | 75 |
| FII | 0.33 | 0.33 | 0.17 | 0.17 | 0.17 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 24.67 | 24.67 | 24.83 | 24.83 | 24.83 | 25 | 25 | 25 | 25 | 25 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.95 | 0.95 | 0.95 | 0.95 | 0.95 | 0.95 | 0.95 | 0.95 | 0.95 | 0.95 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 0.31 | 0.31 | 0.31 | 0.31 | 0.31 | 0.32 | 0.32 | 0.32 | 0.32 | 0.32 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1.26 | 1.26 | 1.26 | 1.26 | 1.26 | 1.26 | 1.26 | 1.26 | 1.26 | 1.26 |
* The pros and cons are machine generated.
You May Also Know About
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.